ProMedica Toledo Hospital Among the First Hospitals in the Nation to Offer New Heart Valve Replacement
posted on: 02/17/2012
Top: Edwards SAPIEN transcatheter heart valve. Bottom: new hybrid operating suite at ProMedica Toledo Hospital
About 500,000 people in the US suffer from failing heart valves known as severe aortic stenosis
TOLEDO, Ohio, Jan. 24, 2012 – ProMedica Toledo Hospital (TH) is among the first hospitals in the nation selected to offer a new, nonsurgical heart valve replacement procedure known as Transcatheter Aortic Heart Valve Replacement (TAVR). TAVR is a new option for gravely-ill patients with severe aortic valve stenosis – failing heart valves – who are not candidates for open-heart surgery. High-risk patients will be pre-screened to determine if TAVR is the best option. TAVR was approved by the Food and Drug Administration to treat patients with narrowing heart valves. The transcatheter valve was designed by Edwards Lifesciences based in Irvine, Calif.
“ProMedica is dedicated to bringing the industry’s most cutting-edge treatment options to this region. TAVR promises to extend and enhance the quality of life for some severely-ill patients,” says James Bingle, MD, president, ProMedica Heart and Vascular Institutes.
Aortic stenosis may begin as a result of aging, rheumatic fever or a congenital abnormality. Typically, the valve tissue becomes scarred, inflamed or thickened. Calcium may collect on the valve, reducing the flexibility of the valve leaflets. As a result, patients may experience symptoms like chest pain, fatigue, and shortness of breath, lightheadedness, fainting or difficulty when exercising. When aortic stenosis becomes severe and symptoms develop, it is life-threatening. As many as 50% of aortic stenosis patients with severe symptoms may die within two years due to disease progression.
A multidisciplinary team of interventional cardiologists and cardiothoracic surgeons are in the process of screening regional patients who may benefit from the TAVR procedure. During the procedure, a balloon-expandable heart valve is placed into the body with a catheter. This allows the valve to be inserted through the groin artery instead of the patient having to undergo traditional open-heart surgery. The TAVR procedure will be performed in the hospital’s new heart and vascular hybrid operating suite.
ProMedica Cardiothoracic Surgeon Michael Moront, MD, is a leader in heart valve surgery and a member of the multidisciplinary team. He was instrumental in bringing TAVR to the region and says it will give hope to patients who are out of options.
“A procedure like TAVR has been a long time coming and we are very pleased to be the first hospital in the region to offer it,” says Moront. “As one of the nation’s top 12% of hospitals for heart surgery, patients who receive this treatment can also take comfort in knowing that they are in the hands of some of the nation’s most experienced surgeons.”
ProMedica offers comprehensive and coordinated heart and vascular services through the ProMedica Heart and Vascular Institutes. The goal of the institutes is to enhance the quality of patient care by interdisciplinary collaboration and a system-wide treatment approach to patients with heart and vascular conditions.
If you have questions about TAVR, call 419-291-2077.
ProMedica Toledo Hospital is a member of ProMedica, a mission-based organization that is ranked the No. 2 most integrated health system in the U.S. ProMedica was formed in 1986 and is a Toledo, Ohio-based, not-for-profit healthcare organization with nearly 14,000 employees; 3,000 physicians and more than 306 facilities in Ohio and Michigan. ProMedica serves more than 2.73 million patients annually and includes 11 hospitals; ProMedica Continuum Services with senior, hospice, rehabilitation, and integrative services; ProMedica Physicians, a network of more than 315 primary care and specialty physicians; and Paramount Health Care, the largest HMO in northwest Ohio.